ATA-200 Dose-escalation Gene Therapy Trial in Patients With LGMDR5
Status : NOT YET RECRUITING
Sponsor: Atamyo Therapeutics
A Gene Transfer Therapy Study to Evaluate the Safety of SRP-9004 (Patidistrogene
Bexoparvovec) in Participants With Limb-Girdle Muscular Dystrophy, Type 2D (LGMD2D)
Status : COMPLETED
Sponsor: Sarepta Therapeutics, Inc.
Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
Status : COMPLETED
Sponsor: Nationwide Children's Hospital
Gene Delivery Clinical Trial of SRP-9003 (Bidridistrogene Xeboparvovec) for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
Status : ACTIVE, NOT RECRUITING
Sponsor: Sarepta Therapeutics, Inc.
A Gene Transfer Single Dose Study to Evaluate the Safety, Tolerability and Efficacy of SRP-9003 in Non-Ambulatory and Ambulatory Participants With Limb Girdle Muscular Dystrophy, Type 2E/R4 (Beta-Sarcoglycan [β-SG] Deficiency)
Status : ACTIVE, NOT RECRUITING
Sponsor: Sarepta Therapeutics, Inc.
A Trial to Learn More About an Experimental Gene Therapy Called Bidridistrogene Xeboparvovec (SRP-9003) as a Possible Treatment for Limb Girdle Muscular Dystrophy 2E/R4 (EMERGENE)
Status : RECRUITING
Sponsor: Sarepta Therapeutics, Inc.
A Study of the Natural History of Participants With LGMD2E/R4, LGMD2D/R3, LGMD2C/R5, and LGMD2A/R1 ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice Status : RECRUITING Sponsor: Sarepta Therapeutics, Inc.
Long-Term Development of Muscular Dystrophy Outcome Assessments (GRASP-01-005) Status : ACTIVE, NOT RECRUITING Sponsor: Virginia Commonwealth University
Natural History Study in Patients With LGMDR5/2c
Status : NOT YET RECRUITING
Sponsor: Atamyo Therapeutics
Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2E (NeuroLGMD2E)
Status : COMPLETED
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicos
Limb Girdle Muscular Dystrophy Type 2E Recruitment Study
Status : RECRUITING
Sponsor: Nationwide Children's Hospital
Natural History of Limb Girdle Muscular Dystrophy Type 2A and Type 2E
Status : RECRUITING
Sponsor: Linda Pax Lowes
The cost of LGMD research extends beyond finances, reflecting a global commitment of time and effort. Financial requirements at each stage provide a roadmap for progress towards treatments and cures.
Drug Development Program